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ABSTRACT Defects of the translation apparatus in human mitochondria are known to cause 
disease, yet details of how protein synthesis is regulated in this organelle remain to be un-
veiled. Ribosome production in all organisms studied thus far entails a complex, multistep 
pathway involving a number of auxiliary factors. This includes several RNA processing and 
modification steps required for correct rRNA maturation. Little is known about the matura-
tion of human mitochondrial 16S rRNA and its role in biogenesis of the mitoribosome. Here 
we investigate two methyltransferases, MRM2 (also known as RRMJ2, encoded by FTSJ2) 
and MRM3 (also known as RMTL1, encoded by RNMTL1), that are responsible for modifica-
tion of nucleotides of the 16S rRNA A-loop, an essential component of the peptidyl trans-
ferase center. Our studies show that inactivation of MRM2 or MRM3 in human cells by RNA 
interference results in respiratory incompetence as a consequence of diminished mitochon-
drial translation. Ineffective translation in MRM2- and MRM3-depleted cells results from aber-
rant assembly of the large subunit of the mitochondrial ribosome (mt-LSU). Our findings show 
that MRM2 and MRM3 are human mitochondrial methyltransferases involved in the modifica-
tion of 16S rRNA and are important factors for the biogenesis and function of the large sub-
unit of the mitochondrial ribosome.
INTRODUCTION
Mitochondria supply energy to the cell through the process of oxi-
dative phosphorylation (OXPHOS) and are involved in many other 
important cellular processes, such as calcium homeostasis, heme 
biosynthesis, apoptosis, and possibly aging. Mitochondria have 
retained an independent organellar translation machinery, which is 
necessary for the synthesis of the 13 polypeptides of the OXPHOS 
system encoded by mitochondrial DNA (mtDNA). The RNA com-
ponents of the mitochondrial translation machinery (2 mt-rRNAs 
and 22 mt-tRNAs) are also encoded by mtDNA, whereas all pro-
tein components, including the proteins of the mitochondrial ribo-
somal subunits, translation factors, aminoacyl tRNA synthetases, 
RNA-modifying enzymes, and other auxiliary factors, are encoded 
by nuclear genes and delivered to mitochondria from the cytosol.
Human mitoribosomes consist of a large subunit (mt-LSU) and 
a small subunit (mt-SSU) of 39 and 28S, respectively, with the en-
tire ribosome having a sedimentation coefficient of 55S (O’Brien, 
2003). Mitochondrial factors must exist to facilitate mitoribosome 
production in order to modulate its function in response to various 
stimuli, similar to ribosomes in other systems. In mammalian mito-
chondria only a handful of such proteins have been identified 
(most of these only very recently), and their exact roles remain elu-
sive (Metodiev et al., 2009, 2014; Dennerlein et al., 2010; Camara 
et al., 2011; He et al., 2012; Rorbach et al., 2012; Kotani et al., 
2013; Wredenberg et al., 2013; Dalla Rosa et al., 2014). Effective 
ribosome production and function also depends on the matura-
tion of rRNAs through a number of posttranscriptional nucleotide 
modifications (Venema and Tollervey, 1999). rRNA modifications 
consist mostly of base methylation, 2′-O-ribose methylation, and 
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in the modification of nucleotides of the 16S rRNA A-loop, specifi-
cally Um1369 and Gm1370, respectively. Both proteins are found to 
be associated with mitoribosomes, and their down-regulation leads 
to defects in mitochondrial protein synthesis and respiratory defi-
ciency, likely due to the disruption of mt-LSU assembly. Our findings 
provide additional support for the notion that MRM2 and MRM3 are 
important factors for the proper functioning of the mitochondrial 
translational machinery.
RESULTS
Modifications of the human mitochondrial LSU rRNA A-loop
We began by experimentally determining the modification status 
of the A-loop nucleotides in human mitochondrial 16S rRNA. To 
this end, we performed reverse transcription primer extension (RT-
PEx) analysis as previously described (Pintard et al., 2002a). This 
assay is based on specific pausing of radioactive primer extension 
by a reverse transcriptase when a 2′-O-ribose modification is en-
countered. On the basis of the predicted secondary structure of 
the human mitochondrial 16S rRNA, we localized the A-loop to 
between nucleotides 1364 and 1378 (mtDNA positions 3034 and 
3048, respectively; Figure 1B). We then extended a primer that 
binds to the 16S rRNA region downstream from the A-loop (1396–
1377; Figure 1C). To enrich the 16S rRNA template, we isolated 
mitochondria from HeLa cells and then performed sucrose gradi-
ent sedimentation followed by isolation of mitochondrial RNA 
from fractions containing mtLSU (Figure 1D, fraction 6). RT-PEx 
identified two discrete pause sites at nucleotides U1369 and 
G1370 (Figure 1E), consistent with these nucleotides being modi-
fied in a similar manner to the corresponding modifications identi-
fied previously in hamster LSU rRNA (Um1370 and Gm1371). This 
result indicates that the human mitochondrial rRNA A-loop also 
contains well-conserved modifications of U1369 and G1370.
Identification and cellular localization of putative human 
2′-O-MTases of the mitochondrial LSU 16S rRNA
Having confirmed the presence of U1369 and G1370 modifications 
in the LSU A-loop nucleotides in human mitochondria, we set out to 
determine the enzymatic machinery responsible for introducing 
these modifications. Thus far, snoRNAs have not been detected in 
mitochondria and, similar to the case for bacteria, yeast mitochon-
drial rRNA modifications depend on site-specific enzymes that are 
not guided by small RNAs (Sirum-Connolly et al., 1995; Pintard 
et al., 2002a). Therefore we assumed that human mitochondrial 
U1369 and G1370 will be modified by site-specific enzymes. All 
known 2′-O-MTases identified thus far belong to either the FtsJ-like 
(class I) or SpoU-type (class IV) protein families (Schubert et al., 
2003).
We first searched the human genome for homologues of FtsJ-
like MTases using E. coli FtsJ/RrmJ uridine 2′-O-MTase (which modi-
fies U2552 in LSU rRNA) and Mrm2p (which modifies U2791 in the 
yeast mitochondrial LSU 21S rRNA) as queries in PSI-BLAST searches. 
Both of these ribose-methylated nucleotides correspond to U1369 
in the human mitochondrial 16S rRNA (Figure 1A). This search iden-
tified five human proteins (coding genes given in parentheses): 
hMTr1 (FTSJD2), hMTr2 (FTSJD1), TRM7 (FTSJ1), MRM2/RRMJ2 
(FTSJ2), and SPB1 (FTSJ3; Figure 2A). The role of hMTr1 (FTSJD2) 
and hMTr2 (FTSJD1) in human cells was established previously, and 
both of these proteins function outside of mitochondria (Belanger 
et al., 2010; Werner et al., 2011). Of the remaining three proteins, 
MRM2/RRMJ2 is the closest homologue of the yeast mitochondrial 
Mrm2p and E. coli FtsJ/RrmJ. Previous ancestry analysis suggested 
that MRM2/RRMJ2 was brought into the eukaryotic cell via the 
pseudouridylation, which can occur at various stages of ribosome 
production and are conserved between Prokaryota and Eukaryota. 
Base methylation is performed by specific methyltransferases 
(MTases; Motorin and Helm, 2011). However, the processes of 
2′-O-ribose methylation and pseudouridine conversion, although 
common to both Prokaryota and Eukaryota, involve different 
mechanisms in these two groups. In eukaryotes, enzymes that 
modify cytosolic rRNAs depend on a number of small nucleolar 
RNAs (snoRNAs) to mark their target nucleotide by forming a tran-
sient duplex with the precursor. In contrast, prokaryotic rRNA 
modifications are performed by several site-specific enzymes that 
recognize their target without a guide RNA (Motorin and Helm, 
2011).
The modifications made to rRNAs have been mapped for 
mammalian mitoribosomes using hamster cells (Dubin, 1974; 
Dubin and Taylor, 1978; Dubin et al., 1978; Baer and Dubin, 1980, 
1981). This analysis showed that only nine rRNA nucleotides 
are modified in mitochondrial rRNAs, compared with >200 in 
eukaryotic cytosolic rRNAs and >30 in bacterial rRNAs (Piekna-
Przybylska et al., 2008). Five bases of the mammalian mt-SSU 
rRNA (12S rRNA) are methylated: m5U429, m4C839, m5C841, 
m62A936, and m62A937 (using human 12S numbering), whereas 
the mt-LSU rRNA (16S rRNA) contains three 2′-O-ribose methy-
lated nucleotides— Gm1145, Um1369, and Gm1370—as well as 
one pseudouridylated base, Psi1397 (using human 16S number-
ing). The Um1369 and Gm1370 modifications of the mitochon-
drial 16S rRNA are predicted to lie in the LSU A-loop, which is an 
essential component of the peptidyl transferase center (PTC) 
implicated in the interaction of the ribosome with an aminoacyl 
(A)-site tRNA (Decatur and Fournier, 2002). This structure is well 
conserved through evolution between bacterial, cytosolic, and 
organellar ribosomes. Significantly, highly conserved nucleotides 
in the A-loop often contain 2′-O-methylation of ribose, namely, 
2′-O-methyluracil (Escherichia coli, Um2552; yeast cytosol, 
Um2921) and 2′-O-methylguanosine (yeast cytosol, Gm2922; 
Figure 1A). Previous studies also revealed that the yeast mito-
chondrial LSU rRNA A-loop contains 2′-O-methylated ribose 
(Um2791; Figure 1A) and that this modification is crucial for ribo-
some function (Pintard et al., 2002a). However, nothing is known 
about the specific function of these modifications or whether 
these nucleotides are also modified in human mitochondria 
(Rorbach and Minczuk, 2012).
Studies in yeast and mouse models indicated that, similar to the 
situation in bacteria, mitochondrial rRNA modifications depend on 
site-specific enzymes rather than being guided by small RNAs 
(Sirum-Connolly et al., 1995; Metodiev et al., 2009). TFB1M (and to 
some extent its paralogue TFB2M) is capable of the dimethylation 
of two very highly conserved adenines in a stem-loop near the 3′ 
end of 12S rRNA (m62A936 and m62A937) in mammalian mitochon-
dria (Seidel-Rogol et al., 2003; Metodiev et al., 2009). NSUN4 is an 
m5C MTase responsible for methylation of m5C841 of 12S rRNA 
(Metodiev et al., 2014). A recent study by Lee et al. (2013) identified 
three novel putative mitochondrial methyltransferases, MRM1 (en-
coded by MRM1), MRM2 (also known as RRMJ2, encoded by FTSJ2) 
and RMTL1 (encoded by RNMTL1), with suggested roles in modifi-
cation of the three known modified 2′-O-ribose bases of the 16S 
rRNA. The same study suggested a role for RMTL1 in methylation of 
G1370 of human 16S rRNA.
In this work we corroborate and extend the data on the roles of 
MRM2 (RRMJ2) and RMTL1, which we renamed MRM3, in mito-
chondria. We additionally show further independent evolutionary 
and experimental evidence on the involvement of MRM2 and MRM3 
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SpoU superfamily (Anantharaman et al., 2002). Several enzymes 
from this group have been identified as 2′-O-MTases, including the 
bacterial guanosine 2′-O-MTase RlmB responsible for the formation 
of Gm at nucleotide 2251 of the E. coli LSU rRNA (Lovgren and 
Wikstrom, 2001) and Pet56p (Mrm1p, YOR201C), which introduces 
a Gm modification in the yeast mitochondrial LSU rRNA at position 
2270 (Sirum-Connolly and Mason, 1993). Using E. coli RlmB and 
yeast Pet56p as queries in PSI-BLAST homology searches, we identi-
fied three human proteins (coding genes given in parentheses): 
TARBP1/TRP-185 (TARBP1), MRM1 (MRM1), and RMTL1 (RNMTL1; 
Figure 2A). The TARBP1 protein was previously characterized as a 
nuclear-localized factor that regulates RNA polymerase II binding to 
HIV-1 RNA regulatory element (TAR; Wu-Baer et al., 1995). The func-
tions of MRM1 and RMTL1 in human cells have not been extensively 
studied. Given the strong homology to well-characterized SpoU-
type guanosine 2′-O-MTases (Supplemental Figure S2) and the ob-
servation that both protein sequences exhibit a high probability of 
mitochondrial endosymbiotic merger, followed by gene duplication 
events that resulted in the occurrence of TRM7 and SPB1 (Pintard 
et al., 2002b; further details in the Supplemental Text). The avail-
ability of three-dimensional structures of E. coli FtsJ/RrmJ uridine 
2′-O-MTase (Bugl et al., 2000) and human MRM2 (unpublished 
structure, Protein Data Bank ID: 2NYU) permitted a comparison of 
the catalytic sites of these two enzymes, revealing a high degree of 
similarity (Supplemental Figure S1). The MRM2 protein sequence 
also has a high probability of possessing a mitochondrial targeting 
sequence (MTS) as analyzed by several computer programs 
(MitoProtII, 0.63; TargetP, 0.60; Predotar, 0.64; MultiLoc, 0.88). The 
human MRM2 protein is therefore a putative uridine 2′-O-MTase 
and a plausible candidate for modification of U1369 in the human 
mitochondrial 16S rRNA.
To identify other candidate enzymes for the modification of nu-
cleotides in the human mitochondrial 16S rRNA A-loop, we also 
searched the human genome for homologues of MTases from the 
FIGURE 1: Modification of the 16S rRNA A-loop in human mitochondria. (A) Comparison of the modification status of 
LSU A-loops across the tree of life. The various modifications reported previously in the LSU rRNA A-loop from E. coli 
(Caldas et al., 2000b), yeast mitochondria (Pintard et al., 2002a), and hamster (Dubin, 1974; Dubin and Taylor, 1978; Baer 
and Dubin, 1981) and the yeast cytosol are indicated. (B) The predicted secondary structure of human mitochondrial 16S 
rRNA. Human mitochondrial 16S rRNA was folded using the thermodynamics-based method of Zuker and Turner (Fields 
and Gutell, 1996) and downloaded from the Comparative RNA Web (CRW) database (Cannone et al., 2002). The 
position of the A-loop is indicated by a gray box. (C) Strategy of primer extension used to detect modifications of the 
A-loop in human mitochondrial 16S rRNA. The sequence encompassing the 16S rRNA A-loop is shown (16S nucleotide 
positions: 1325–1397). The position of the primer (pAL) used for reverse transcription primer extension (RT-PEx) is 
indicated in red. (D) Fractionation of the mitochondrial ribosome. Mitochondria that were isolated from HeLa cells were 
lysed, separated through a 10–30% (wt/vol) isokinetic sucrose gradient, and fractionated. Ten fractions were collected 
and analyzed by Western blotting using antibodies specific for a component of mt-LSU (MRPL3) and a component of 
mt-SSU (MRPS18B). (E) Detection of the A-loop modifications in human mitochondrial 16S rRNA. RNA isolated from 
fractions 3 and 6 of the sucrose gradient from D was subjected to RT-PEx using a radioactively labeled primer as shown 
in C, using two concentrations of dNTPs as indicated. Samples were analyzed on a 15% denaturing polyacrylamide gel 
and subjected to autoradiography. The specific pausing sites for 16S rRNA nucleotide positions U1369 (blue) and G1370 
(green) are indicated.
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revealed that the recombinant proteins colocalized with mitochon-
dria (Figure 2B). Cell fractionation experiments confirmed the mito-
chondrial localization of the three proteins, as the endogenous pro-
teins cofractionated with the well-characterized mitochondrial matrix 
protein mtSSB1 and were resistant to proteinase K treatment 
(Figure 2C). In similar conditions the outer membrane protein 
TOM22 was truncated by proteinase K. These results demonstrate 
that MRM1, MRM2, and MRM3 are localized within the mitochon-
dria of human cells.
mitochondrial import (MRM1 and MRM3: MitoProtII, 0.97 and 0.96; 
TargetP, 0.92 and 0.89; Predotar, 0.84 and 0.63; MultiLoc, 0.19 and 
0.96), MRM1 and RMTL1 appear to be good candidates for guano-
sine 2′-O-methyl modification of mitochondrial 16S rRNA. For 
consistency, we renamed the RMTL1 protein MRM3 (mitochondrial 
rRNA MTase 3).
To study experimentally the cellular localization of MRM1, MRM2, 
and MRM3, we transiently expressed the corresponding cDNAs, 
containing a FLAG tag, in HeLa cells. Immunofluorescence analysis 
FIGURE 2: Identification and mitochondrial localization of human FtsJ-like and SpoU-type MTases. (A) Human FtsJ-like 
and SpoU-type MTases. Several FtsJ-like and SpoU-type MTases identified in the human genome are shown 
schematically. Three MTases, MRM1, MRM2, (FTSJ2) and MRM3 (RMTL1), have a predicted mitochondrial targeting 
sequence (MTS). Other domains present in the MTases analyzed are also indicated. (B) The intracellular localization of 
MRM1, MRM2, and MRM3 MTases by immunofluorescence. The cDNA encoding the STREP2- and FLAG-tagged 
variants of each MTase was transiently transfected into HeLa cells. Mitochondria were stained with MitoTracker Red 
CMXRos (red, 1). MRM1, MRM2, or MRM3 were detected using an anti-FLAG antibody and visualized using secondary 
antibodies conjugated with FITC (green, 2). Cell nuclei were stained with DAPI (blue, 3). Colocalization of the 
mitochondria-specific red signal and MTase-specific green signal appears yellow on digitally merged images (4). 
(C) Localization of MRM1, MRM2, and MRM3 MTases in subcellular fractions. HeLa cells were fractionated into debris 
(D, lane 2), cytosol (C, lane 3), and mitochondria (lanes 4–6). The mitochondrial fraction was treated with 25 μg/ml 
proteinase K in the absence (lane 5) or presence of 1% Triton X-100 (lane 6). T, total cell lysate. The fractions were 
analyzed by Western blotting using antibodies to each MTase. The distribution of MTases was compared with that of the 
following marker proteins: mtSSB1 (mitochondrial matrix), TOM22 (mitochondrial outer membrane), GAPDH (cytosol), 
and histone H4 (nucleus). fl, TOM22 of full length; tr, truncated TOM22.
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were found to be broadly distributed across Archaea, Bacteria, and 
Eukaryota (Supplemental Text). Second, we queried published data 
for reports on 2′-O-ribose methylation in the LSU A-loops of prokary-
otic organisms and mitochondria, in which posttranscriptional modi-
fications of rRNA are introduced by site-specific enzymes. This latter 
step of analysis, however, was hindered by the fact that very few 
eukaryotic species have been analyzed for the presence of modifi-
cations in their mitochondrial LSU rRNAs. Therefore we experimen-
tally analyzed the mitochondrial LSU rRNA A-loop modifications in 
several eukaryotes (Caenorhabditis elegans, Drosophila melano-
gaster, Danio rerio) using RT-PEx of mitochondrial or total RNA 
preparations from these organisms. We first confirmed the previ-
ously published result that Saccharomyces cerevisiae contains only 
Orthologues of the MRM proteins and modification 
of mitochondrial LSU rRNA across evolution
Next we set out to assign which of the identified MRM candidates 
are responsible for specific modifications of the LSU A-loop in hu-
man mitochondria. To this end, we investigated the correlation be-
tween the evolutionary occurrence of MRM orthologues and the 
presence of modified nucleotides corresponding to U1369 and 
U1370 in the LSU rRNA A-loop in prokaryotic organisms and mito-
chondria from other species. First, we examined the distribution of 
MRM1, MRM2, and MRM3 via reciprocal best BLAST hits across the 
147 fully sequenced genomes (Reference Proteomes, 2013_04 re-
lease; Gabaldon et al., 2009; Figure 3A, Supplemental Figure S3, 
and Supplemental Text). Homologues of the three MRM proteins 
FIGURE 3: Evolutionary distribution of MTase orthologues and specific modification of the A-loop of LSU rRNA. 
(A) Evolutionary analysis of human MRM1, MRM2, and MRM3 across higher taxa. The tree shows higher taxa for human 
MRM1, MRM2, and MRM3 based on National Center for Biotechnology Information taxonomy and reciprocal BLAST 
hits computed for 147 fully sequenced genomes (Reference Proteomes, 2013_04 release). The percentage of hits within 
a taxon is shown by a grayscale, with the darker tones representing the higher percentages. Light gray may indicate the 
presence of evolutionary divergence within the taxon, incomplete proteome data, or limitations of the reciprocal BLAST 
approach. (B) Detection of A-loop modifications in mitochondrial LSU rRNAs of several eukaryotic species. RNA isolated 
from S. cerevisiae, C. elegans, D. melanogaster, and D. rerio was subjected to RT-PEx using a radioactively labeled 
primer binding upstream from the A-loop. Samples were analyzed on a 15% denaturing polyacrylamide gel and 
subjected to autoradiography. The specific pausing sites for the LSU rRNA A-loop are indicated. Nucleotide positions 
that correspond to human 16S rRNA U1369 are indicated in blue, whereas those corresponding to human 16S rRNA 
U1370 are in green. (C) Correlation between the presence of MTase orthologues and specific modifications of the 
A-loop. The presence of MRM1 (red), MRM2 (blue), or MRM3 (green) in analyzed species is indicated by filled squares. 
Open squares indicate that an orthologue has not been identified. The modification status of LSU nucleotides 
corresponding to the human 16S residues U1369 (blue) and G1370 (green) is represented by circles. Open circles 
indicate a lack of modification; filled circles indicate that the nucleotide is modified. The data for Bacillus subtilis are 
those of Hansen et al. (2002), and other references can be found in the text.
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LSU mt-rRNA. In D. melanogaster and D. 
rerio, in addition to this conserved U nucle-
otide (U1579 and U1484, respectively), the 
G nucleotide that corresponds to human 
mitochondrial 16S G1370 was also modi-
fied (G1580 and G1485, respectively; 
Figure 3B). Finally, comparing the evolu-
tionary distribution of the MRM proteins 
with the presence of particular modifica-
tions in the A-loop revealed the following 
relationships: 1) The nucleotide correspond-
ing to human mitochondrial LSU rRNA 
U1369 is modified in species in which MRM2 
is present (Figure 3C, blue), supporting our 
sequence/structure analysis-based predic-
tion that this protein is responsible for mod-
ification of this conserved uridine in the hu-
man 16S A-loop (see earlier discussion); 
2) modification of the position correspond-
ing to human mitochondrial LSU rRNA 
G1370 correlates with the evolutionary 
presence of MRM3 (Figure 3C, green), sug-
gesting that this protein is responsible for 
modification of this conserved guanosine in 
the human 16S rRNA A-loop; and 3) the 
evolutionary distribution of MRM1 does not 
coincide well with modification of either 
U1369 or G1370 (Figure 3C, red).
RNA interference silencing of MRM2 
or MRM3 affects modification of the 
16S rRNA A-loop in human 
mitochondria
To confirm our computational predictions 
experimentally, we studied the modifica-
tions of the human 16S rRNA A-loop upon 
small interfering RNA (siRNA) silencing of 
the three MRM candidates using RT-PEx. 
Two primers were used for each PEx reac-
tion: the A-loop–specific primer (Figure 4A, 
pAL) was designed to detect reverse tran-
scriptase pausing at U1369 and G1370, 
whereas a primer that anneals at the 5′ end 
of 16S rRNA and produces a runoff tran-
script (Figure 4A, p5LSU) was used to pro-
vide standardization. Initial tests demon-
strated that it is feasible to use total RNA 
preparations from HeLa cells and a combi-
nation of the two primers in RT-PEx reac-
tions (Figure 4B). We silenced the three 
MRM proteins in HeLa cells using three dif-
ferent siRNA oligonucleotides in each case 
(Supplemental Figure S4) and selected the 
most efficient oligonucleotides for further 
analysis (Figure 4C). After 9 d of depletion 
of each MRM transcript in HeLa cells 
(achieved by three subsequent transfections 
of siRNA in a 3-d interval), we applied RT-
PEx to analyze the A-loop modifications of 
16S mt-rRNA. The degree of pausing at 
U1369 and G1370 (Figure 4D, blue and green) was compared with 
the amount of runoff transcription at the 5′ end of 16S mt-rRNA 
(Figure 4D, “RO-”). Quantitative analysis of three independent 
one modification of the LSU A-loop, at position U2791, correspond-
ing to human U1369 (Figure 3B). A single modification at the corre-
sponding position (U808) was also present in the A-loop of C. elegans 
FIGURE 4: siRNA depletion of MRM2 and MRM3 perturbs LSU rRNA A-loop modifications. 
(A) Strategy for primer extension to measure levels of the A-loop modifications in human 
mitochondrial 16S rRNA. The location of primers used for reverse transcription primer extension 
(RT-PEx) are indicated in red. The pAL primer detects the modifications of U1369 (blue) and 
G1370 (green), whereas the p5LSU primer is used to standardize the loading of 16S rRNA. 
(B) Detection of the A-loop modifications of human mitochondrial 16S rRNA in total RNA 
preparations. Radioactively labeled primers as per A were extended separately (left) or 
simultaneously (right) in a RT-PEx reaction using total RNA isolated from HeLa cells using two 
concentrations of dNTPs as indicated. Reaction products were separated on a 15% (wt/vol) 
denaturing polyacrylamide gel and subjected to autoradiography. The specific pausing sites upon 
extension of the pAL primer at nucleotide positions U1369 and G1370 are indicated by blue and 
green lollipops, respectively. RO-, the runoff product resulting from extending the p5LSU primer. 
The asterisk denotes an unspecified band resulting from RT-PEx of the p5LSU primer using the 
lower dNTP concentration. (C) RNA interference knockdown of MTases. Steady-state protein 
levels of the endogenous MRM1, MRM2, and MRM3 proteins analyzed by Western blotting in 
control HeLa cells transfected with an unrelated siRNA (Ctrl) or cells transfected with selected 
siRNAs specific for a particular MTase for 9 d. β-Actin was used as loading control. (D) 16S rRNA 
A-loop modifications upon siRNA knockdown of MRM1, MRM2, or MRM3 Total RNA isolated 
from control HeLa cells or cells transfected with siRNA to MTases was analyzed using RT-PEx as 
depicted in A and B. Specific pausing at modified nucleotides U1369 and G1370 is indicated by 
blue or green lollipop, respectively. The runoff product used for normalization is indicated as RO-. 
(E) Relative ratios between A-loop–specific and runoff 16S rRNA RT-PEx products in cells treated 
with siRNA to MTases. RT-PEx reactions as per D were quantified using ImageQuant software, 
and the ratios U1369/RO and G1370/RO were plotted relative to controls for three independent 
siRNA transfection experiments. n = 3; error bars, 1 SD.
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experiment, endogenous MRM2 was coimmunoprecipitated by 
proteins from both the large and small ribosomal subunits. In con-
trast, MRM3 was pulled down only by ICT1, a large-subunit protein 
(Figure 6, C and D). The specificity of detected interactions was con-
firmed by probing the elution fractions for NDUFB8 as before. It was 
reported previously that ICT1.FLAG and MRPS27.FLAG not only are 
able to pull-down components of mt-SSU or mt-LSU, respectively, 
but that each of these proteins is also capable of pulling down the 
entire 55S monosome (Richter et al., 2010). Indeed, proteins of mt-
LSU were present in the elution fraction of the MRPS27.FLAG im-
munoprecipitation, consistent with copurification of the intact mito-
chondrial monosome. Because MRM2 was present in both the ICT1.
FLAG and the MRPS27.FLAG elution fractions, it is possible that the 
protein interacts with either of the subunits or with the mitochon-
drial monosome. The lack of MRM3 in the MRPS27.FLAG elution 
indicates that the protein does not bind to the fully assembled 55S 
mitoribosome.
These observations were further investigated by analysis of mito-
ribosomes using sucrose gradient centrifugation. We carried out a 
gradient analysis of HEK293T cells using antibodies against MRPL12 
and MRPS18B to visualize the large and small mitoribosomal sub-
units, respectively. We could not readily detect endogenous MRM2 
comigrating with markers of the mitochondrial ribosomal subunits, 
likely due to the low abundance of the mitoribosome-associated 
protein (Supplemental Figure S5). Therefore we expressed MRM2 
tagged with a FLAG tag in HEK293T cells, allowing more sensitive 
detection by anti-FLAG monoclonal antibody. Consistent with our 
initial coimmunoprecipitation (co-IP) experiments (Figure 6A, C and 
D), a small proportion of MRM2.FLAG comigrated with mt-LSU 
(Figure 6E, fractions 10 and 11) and larger protein assemblies 
(Figure 6E, fractions 14 and 15). In a similar sucrose gradient analy-
sis, endogenous MRM3 was found to be partially associated with 
mt-LSU (Figure 6F, fractions 9–11), fully corroborating the results of 
the co-IP analysis (Figure 6, B–D).
In conclusion, our co-IP experiments suggest that a portion of 
the mitochondrial pool of MRM2 associates with mt-LSU. The MRM2 
co-IP pattern is also consistent with association of this protein with 
the 55S monosome. Sucrose gradient sedimentation analysis of a 
tagged protein confirms association of MRM2 with mt-LSU. The 
presence of MRM2 in the higher sucrose gradient fractions further 
suggests association with larger mitochondrial ribosome assemblies, 
likely the 55S monosome (often not easily detectable by the sucrose 
gradient in proliferating cells; Dennerlein et al., 2010; Richter et al., 
2010, 2013). The results of co-IP experiments and sucrose gradient 
sedimentation indicate that a fraction of MRM3 interacts with mt-
LSU but not with the fully assembled monosome (Figure 6G).
Loss of MRM2 and MRM3 alters the sedimentation profile 
of mt-LSU
To further characterize the molecular basis for the observed transla-
tion defect upon MRM2 or MRM3 knockdown, especially in the con-
text of their interaction with the mitoribosome, we examined the 
integrity of mitochondrial ribosomes by ultracentrifugation of cell 
extracts through sucrose gradients. Silencing of MRM2 expression 
for 9 d revealed 20–30% reduction in levels of assembled 39S mito-
ribosomal subunits (Figure 7, A and B), manifested as reduction in 
signal from the MRPL12 protein incorporated into mt-LSU (Figure 7, 
A and B, fractions 9–12) relative to the pool of free MRPL12 (Figure 7, 
A and B, fractions 1–3). The profile of the mt-SSU marker, MRPS18B, 
was not markedly changed after MRM2 depletion. Next we exam-
ined the levels of mt-rRNAs in individual sucrose gradient fractions 
of cell lysates from controls and cells treated with RNAi to MRM2 
siRNA/RT-PEx experiments (Figure 4E) revealed that 1) siRNA silenc-
ing of MRM1 does not affect any of the 16S rRNA A-loop modifica-
tions, 2) down-regulation of MRM2 results in a significant loss of the 
U1369 modification, although the G1370 is also affected, and 
3) knockdown of MRM3 predominantly affects modification of 
G1370, with only a minor effect on U1369. Taken together, these data 
indicate that MRM2 and MRM3, but not MRM1, play a role in post-
transcriptional modification of the A-loop residues of 16S mt-rRNA. 
In particular, RT-PEx experiments clearly confirm our previous in silico 
prediction that MRM3 is responsible for modification of the G1370 
residue of the 16S mt-rRNA A-loop. Furthermore, MRM2 has been 
suggested to be a U1369 2′-O-ribose methylase by sequence/three-
dimensional (3D) structure homology–based computational compari-
sons (Supplemental Figure S1), as well as the evolutionary cooccur-
rence of the A-loop uridine modification with MRM2 homologues 
(Figure 3C). The strong effect of MRM2 silencing upon the U1369 
modification is therefore compatible with this prediction.
Depletion of MRM2 and MRM3 perturbs mitochondrial 
function
We next set out to determine the functional consequences of a re-
duction of methylation of the LSU A-loop after depletion of MRM2 
and MRM3. De novo labeling of mitochondrial protein synthesis 
products, followed by gel electrophoresis and autoradiography, 
showed a significant inhibition of translation in mitochondria of cells 
subjected to MRM2 or MRM3 RNA interference (RNAi; Figure 5A). 
The overall rate of mitochondrial protein synthesis in the MRM2 or 
MRM3 siRNA transfectants was ∼50 and 35%, respectively, com-
pared with that of cells transfected with an unrelated control siRNA 
(Figure 5B). In both cases, the observed decrease in mitochondrial 
translation was accompanied by a reduction of the cellular oxygen 
consumption rate (OCR), consistent with perturbed function of the 
OXPHOS complexes (Figure 5C). When cells were grown in media 
containing galactose as the sole carbon source, which forces depen-
dence on oxidative phosphorylation for ATP production, the MRM2- 
or MRM3-depleted cells showed significantly reduced growth rate, 
with a very pronounced effect in the case of MRM3 (Figure 5D). Fur-
thermore, MRM3-depleted cells showed reduced growth rate when 
cultured in standard medium containing glucose (Figure 5E), effects 
observed previously under conditions of perturbed mitochondrial 
translation (Rorbach et al., 2008).
MRM2 and MRM3 interact with the mitochondrial ribosome
Having shown that MRM2 and MRM3 are responsible for modifica-
tion of nucleotides of the human 16S rRNA A-loop and that deple-
tion of the proteins impairs mitochondrial translation, we were inter-
ested to determine whether these proteins associate with the 
mitochondrial ribosome. To investigate this possibility, we first per-
formed pull-down experiments using FLAG-tagged versions of 
MRM2 or MRM3, which were inducibly expressed in HEK293T cells. 
MRM2-FLAG was found to coimmunoprecipitate substantial quanti-
ties of components of both the mt-LSU (MRPL3 and MRPL12) and 
the mt-SSU (MRPS18B and DAP3/MRPS29). On the other hand, 
MRM3-FLAG was found to efficiently coimmunoprecipitate compo-
nents of mt-LSU but only very marginal amounts of components of 
mt-SSU (Figure 6, A and B). The lack of other highly abundant mito-
chondrial proteins in the elution fractions, such as subunit NDUFB8 
of complex I, suggests specific interaction of MRM2 and MRM3 with 
the mitochondrial ribosome (Figure 6, A and B).
We next performed reciprocal pull-down experiments in which 
either FLAG-tagged ICT1 (a component of mt-LSU) or FLAG-tagged 
MRPS27 (a component of mt-SSU) were used as the bait. In this 
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were no apparent changes in the stability of mt-rRNA in MRM3 
siRNA-treated cells (Supplemental Figure S6). Taken together, these 
observations suggest that both MRM2 and MRM3 are important for 
mt-LSU integrity, mitochondrial protein synthesis, and consequently 
OXPHOS function.
DISCUSSION
MRM2 and MRM3 modify the LSU rRNA A-loop in human 
mitochondria
In this study we set out to determine whether and how the LSU 
rRNA A-loop is posttranscriptionally modified in human 
(Supplemental Figure S6). We detected significant reduction of 
steady-state levels of 16S rRNA in siRNA-treated cells in fractions 
corresponding to mtLSU, consistent with defect in assembly or re-
duced stability of this mitoribosomal subunit. An analogous experi-
ment was performed using cells treated with siRNA against MRM3. 
In this experiment, a significant proportion of the mt-LSU markers 
(MRPL3 and MRPL12) relocated to less dense fractions compared 
with control cells (Figure 7, C and D, fractions 7 and 8), implying that 
the assembly and/or stability of mt-LSU is impaired. The profile of 
the mt-SSU marker MRPS18B was again unchanged, suggesting 
that assembly of mt-SSU is unaffected by depletion of MRM3. There 
FIGURE 5: Mitochondrial translation and OXPHOS function after siRNA depletion of MRM2 or MRM3. 
(A) Mitochondrial translation in cells treated with siRNA to MRM2 or MRM3. Products of mitochondrial translation were 
labeled with [35S]methionine in control cells transfected with an unrelated siRNA (Ctrl) or in cells transfected for 9 d 
with siRNAs specific for MRM2 or MRM3. Mitochondrial proteins were separated by 4–12% gradient SDS–PAGE 
and visualized by autoradiography. To validate equal protein loading, the gel was stained with Coomassie dye. 
(B) Radiolabeled products of mitochondrial translation as per A were quantified using ImageQuant software after 
exposure to a PhosphorImager screen. ***p < 0.001; two-tailed Student’s t test; n = 3; error bars, 1 SD. (C) OCRs in 
MRM2- or MRM3-depleted cells. OCR measured in an extracellular flux Seahorse instrument in control cells transfected 
with an unrelated siRNA or in cells treated with siRNAs to MRM2 or MRM3 for 9 d. The wells were sequentially injected 
with 20 mM 2-DG to inhibit glycolysis, 100 nM oligomycin to inhibit ATP-synthase, 1 μM FCCP to uncouple the 
respiratory chain, and 200 nM rotenone to inhibit complex I. n = 4; error bars, 1 SD. (D, E) Cell growth upon inactivation 
of MRM2 or MRM3. Growth curves obtained by Incucyte kinetic imaging system of parental HEK293 cells (Ctrl) or cells 
transfected with siRNA to MRM2 or MRM3 for 8 d in galactose (D) or glucose (E) medium.
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mitochondria (Figure 3), and, second, on use of siRNA knockdown 
experiments (Figure 4).
The mitochondrial localization of MRM1, MRM2, and MRM3 in 
HeLa cells observed in our studies is in full agreement with the re-
port by Lee et al. (2013) and also with systematic studies of the 
whole human proteome (Human Protein Atlas; Uhlen et al., 2010) 
and the mitochondrial proteome (Mitocarta; Pagliarini et al., 2008).
The assignment of MRM3 to the modification of a conserved 
guanosine, G1370, in the human 16S rRNA A-loop is strongly sup-
ported by sequence and structure homology studies, as well as by 
the evolutionary correlation between the presence of the ortho-
logue with the guanine modification in the A-loop and, most impor-
tant, by siRNA down-regulation experiments. The same conclusion 
regarding the role of MRM3 was reached by Lee et al. (2013). Our 
mitochondria. We confirmed that the 16S rRNA nucleotides U1369 
and G1370, located at the top of the hairpin structure of the A-
loop, are modified in human cells (Figure 1), consistent with previ-
ous descriptions of mt-rRNA modifications in other mammalian 
species (Dubin, 1974; Dubin and Taylor, 1978; Baer and Dubin, 
1981). We identified three members of an MTase family, MRM1, 
MRM2, and MRM3 (renamed from RMTL1, encoded by RNMTL1), 
and found that all three proteins localize to mitochondria in human 
cells (Figure 2). Human MRM2 has been identified as a putative 
uridine 2′-O-MTase responsible for modification of U1369 and 
MRM3 as a putative guanine 2′-O-MTase that modifies G1370, 
based, first, on sequence/structure homology analysis (Supple-
mental Figures S1 and S2) and the evolutionary cooccurrence of 
orthologues with particular A-loop modifications in bacteria and 
FIGURE 6: Interaction of MRM2 and MRM3 with the mitochondrial ribosome. (A, B) IP of components of the 
mitochondrial ribosome using tagged version of MRM3 and MRM3. Mitochondria from HEK293T cells expressing 
MRM2.FLAG (A) or MRM3.FLAG (B) were lysed, and IP was performed using anti-FLAG antibodies. The lysates (Input) 
and eluates were analyzed by Western blotting with antibodies as indicated. NDUFB8, antibody against a subunit of 
mitochondrial complex I. (C, D) IP of endogenous MRM2 and MRM3 using tagged components of the mitoribosome. 
Mitochondria from HEK293T cells expressing a component of mt-LSU (ICT1.FLAG; C) or a component of mt-SSU 
(MRPS27.FLAG; D) were lysed, and IP was performed using anti-FLAG antibodies. The lysates (Input) and eluates were 
analyzed by Western blotting using antibodies as indicated. NDUFB8, antibody against a subunit of mitochondrial 
complex I. (E, F) Cosedimentation of MRM2 and MRM3 with mitochondrial ribosome in sucrose gradients. Total lysates 
of HEK293T cells expressing MRM2.FLAG (E) or untransfected HEK293T cells (F) were separated through a 10–30% (wt/
vol) isokinetic sucrose gradient and fractionated. The fractions were analyzed by Western blotting using antibodies 
specific for the FLAG tag (MRM2), endogenous MRM3, components of mt-LSU (MRPL12 or MRPL3), and a component 
of mt-SSU (MRPS18B). (G) Summary of MRM2 and MRM3 interactions with the mitoribosome. Interpretation of the IP 
and sucrose gradient experiments.
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2004). An alternative explanation may be provided by the technical 
features of the PT-PEx assay used in these experiments. For exam-
ple, 1) the lack of U1369 modification could cause changes in the 
conformation of the RNA template, altering the degree of stalling 
by the reverse transcriptase at the preceding G1370 site, or 2) the 
lack of modification at G1370 could lead to more of the reverse 
transcriptase reaching U1369, influencing the results at this site. Fu-
ture experiments should involve an alternative method for detection 
of the posttranscriptional modifications in mt-rRNA, such as mass 
spectrometry (Suzuki and Suzuki, 2014).
The role of MRM2 and MRM3 proteins in mitoribosome 
biogenesis and function
Chemical modifications of rRNAs are mostly clustered in conserved 
and functionally critical regions of the ribosome. The 2′-O-methylu-
racil and 2′-O-methylguanosine modifications at positions 1369 and 
1370, respectively, are predicted to lie in the A-loop of the LSU 
rRNA in human mitochondria. The A-loop is an essential component 
of the peptidyl transferase center, since it is the docking site for the 
computational sequence/structure analysis and evolutionary distri-
bution studies, combined with experimental data on the LSU A-loop 
modification across various eukaryotic species, is consistent with 
MRM2 being responsible for modification of U1369 in the human 
16S rRNA A-loop. However, experiments in which MRM2 was de-
pleted using siRNA found that, in addition to the primary effect on 
the U1369 modification, G1370 methylation is also affected by de-
pletion of MRM2, albeit to a lesser degree. One explanation for this 
could be interdependence between these two modification events. 
In this situation, the U1369 residue would be modified earlier during 
mitoribosome biogenesis, with the later modification of G1370 be-
ing dependent on this event (see later discussion). To some extent, 
this would be similar to the sequence of events during modification 
of the A-loop during the biogenesis of the cytosolic ribosome in 
yeast. The universally conserved U2921 modification (correspond-
ing to U1369), located within the A-loop of the yeast 28S LSU rRNA, 
is formed at an earlier stage of the biogenesis pathway, whereas the 
G2922 modification (the equivalent of G1370) is introduced at a 
later step, during the maturation of LSU (Lapeyre and Purushothaman, 
FIGURE 7: Mitochondrial ribosome integrity upon siRNA depletion of MRM2 or MRM3. (A) The mitochondrial ribosome 
profile in MRM2-depleted cells. Total cell lysates of control HeLa cells transfected with an unrelated siRNA or HeLa cells 
transfected with siRNA to MRM2 were separated on a 10–30% (wt/vol) isokinetic sucrose gradient. Fractions obtained 
for control and RNAi-treated cells were analyzed by Western blotting using antibodies to mt-LSU (MRPL3, MRPL12) and 
mt-SSU (MRPS18B). (B) Quantification of the gradient distribution of mitoribosomal components upon MRM2 silencing. 
Western blot signals for MRPL3, MRPL12, and MRPS18B for control and MRM2-depleted cells were quantified using 
ImageQuant software. The y-axis represents the fraction of the total signal relative to control cells. n = 3. All significant 
value changes are indicated; *p < 0.05, **p < 0.01, ***p < 0.001; two-tailed unpaired Student’s t test. Error bars, 1 SD. 
(C) The mitochondrial ribosome profile in MRM3-depleted cells. Total cell lysates of control HeLa cells or HeLa cells 
transfected with siRNA to MRM3 were analyzed as per A. (D) Quantification of the gradient distribution of 
mitoribosomal components upon MRM2 silencing. Western blot signal was quantified and analyzed as per B.
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3′ end of the SSU rRNA, has also been proposed to play a role in the 
final stages of monosome assembly. Some earlier data showed that 
extracts from KsgA-deficient E. coli cells have reduced affinity be-
tween the 30 and 50S ribosomal subunits (Poldermans et al., 1980). 
It has further been proposed that KsgA sterically blocks incom-
pletely assembled small ribosomal subunits from entering the trans-
lational cycle prematurely (Xu et al., 2008; Demirci et al., 2010).
Our work also concentrated on 2′-O-ribose methylation of a 
conserved A-loop guanosine residue, G1370, which is performed 
by the human MRM3 protein and is indispensable for correct mito-
chondrial translation and OXPHOS function (Figure 5). Coimmuno-
precipitation and sucrose gradient sedimentation analyses indicate 
that human MRM3 associates with mt-LSU but not with the mono-
some (Figure 6). These data are in full agreement with a recent 
study by Lee et al. (2013). However, our study also provides a par-
tial explanation for this phenotype. Down-regulation of MRM3 ex-
pression using siRNA results in the accumulation of species that 
are consistent with mt-LSU pre-ribosomal particles, likely to be 
late-stage assembly intermediates (Figure 7). The base equivalent 
of G1370 in the human mt-LSU rRNA is not modified in the E. coli 
23S rRNA (G2553), although evidence exists that this residue pairs 
with C75 of the aminoacyl tRNA in the bacterial ribosomal A-site 
(Kim and Green, 1999). Yeast mitochondrial 21S rRNA also does 
not carry a modification at this site (G2792). However, an analo-
gous 2′-O-methylguanosine modification is present in the yeast 
cytosolic LSU 25S rRNA (Gm2922). Unlike other 25S 2′-O-ribose 
methylation events, which are guided by numerous small nucleolar 
RNAs, the formation of Gm2922 is catalyzed by an essential FtsJ-
like MTase called Spb1p. Modification of G2922 is a late event 
occurring on the 27S ribosome intermediate and is essential for 
proper ribosome production (Harnpicharnchai et al., 2001; Lap-
eyre and Purushothaman, 2004). Parallels can therefore be drawn 
between the methylation of guanosine in the A-loop in eukaryotic 
cytosolic ribosomes (by Spb1p) and in the mammalian mitochon-
drial ribosome (by MRM3), in that both modifications are per-
formed by site-specific enzymes, with the modification being nec-
essary for the regulation of ribosome biogenesis and translation. 
The possibility of this modification occurring at a late stage in as-
sembly is supported by structural data indicating that both resi-
dues U1369 and G1370 are potentially accessible to the enzymes 
even on the fully assembled mt-LSU (Greber et al., 2014; Supple-
mental Figure S7).
In conclusion, MRM2 and MRM3 are novel human genes that are 
indispensable for mitochondrial translation via their contributions to 
the modification of 16S rRNA and the biogenesis of mt-LSU. The 
function of MRM3 in mt-LSU is also supported by the recent study of 
Lee et al. (2013). Further studies are required to distinguish whether 
it is the presence of the MRM2 and MRM3 proteins in mitochondria, 
their catalytic activity necessary for modification of 16S mt-rRNA, or 
possibly both that are crucial for mitochondrial ribosome biogene-
sis. In addition, further analysis of these proteins and the identifica-
tion of other factors involved in mitochondrial rRNA modifications 
would provide greater insights into the largely unknown area of mi-
tochondrial ribosome biogenesis pathways.
MATERIALS AND METHODS
Plasmids
To construct plasmids encoding FLAG.STREP2-tagged MRM1, 
MRM2, and MRM3 proteins, cDNAs encoding each protein (MRM1: 
cDNA clone MGC:90266, IMAGE:6164397; MRM2: cDNA clone 
MGC:138620, IMAGE:40031660; MRM3: cDNA clone MGC:60073, 
IMAGE:5248052) were modified by PCR to introduce unique 
incoming aminoacyl (A)-site tRNA, which binds through its 3′-end 
CCA tail. In other systems, enzymes responsible for modifications to 
the A-loop have been shown to play a major role not only in ribo-
some function, but also in its biogenesis.
Our data indicate that 2′-O-ribose methylation of a conserved 
uridine residue, U1369, by the human MRM2 protein is critical for 
proper mitochondrial translation and consequently for mitochon-
drial respiratory function (Figure 5). The role of MRM2 in these pro-
cesses was not studied before. We further show that human MRM2 
associates both with mt-LSU and the mitochondrial monosome. Two 
different methods have been used to this end: 1) reciprocal coim-
munoprecipitation of tagged and endogenous MRM2 proteins with 
components of the mitochondrial ribosome and 2) cofractionation 
of the tagged MRM2 with mitoribosomal subunits upon sucrose 
gradient sedimentation (Figure 6). An association of MRM2 with the 
mitochondrial ribosome was also suggested by Lee et al. (2013), but 
their methodology did not allow for identification of the exact na-
ture of this interaction. Finally, we provide additional data indicating 
that depletion of MRM2 by RNAi affects the stability of mt-LSU 
(Figure 7). The base equivalent of U1369 of human mitochondrial 
16S rRNA was shown to be 2′-O-ribose methylated in the majority 
of organisms investigated (Sirum-Connolly et al., 1995), and model 
organisms have been used to assess the functional role of this modi-
fication. In E. coli, strains that are deficient in RrmJ, which is respon-
sible for methylation of the corresponding position (Um2552) in the 
large 23S rRNA, exhibit growth defects and reduced translation 
rates. RrmJ is active against ribosomes and free LSU but not free 
rRNA. This Um2552 methylation is important for stability of the LSU, 
consistent with a role for this MTase in later stages of bacterial ribo-
some maturation (Caldas et al., 2000a,b). Similarly, deletion of the 
yeast MRM2 gene (responsible for methylation of the correspond-
ing position, Um2791, in mitochondrial LSU rRNA) causes a thermo-
sensitive respiratory growth phenotype (Pintard et al., 2002a). 
Mrm2p cosediments with the large rRNA on sucrose gradients and 
methylates U2791 only when rRNA is assembled into the LSU, again 
suggesting that this modification is required for the later steps of the 
ribosome maturation process (Pintard et al., 2002a). Therefore our 
results indicate that not only is human MRM2 highly similar to the 
bacterial RrmJ and yeast Mrm2p on the sequence level, but it also 
retained an analogous function during ribosome biogenesis. How-
ever, further research is required to study the exact functional role of 
the U1369 modification. It has been shown that, in bacteria, 2′-O-
ribose methylation of the A-loop uridine not only is required for 
proper ribosome biogenesis, but also plays a role in regulating 
translational accuracy. The lack of this modification to the bacterial 
23S rRNA A-loop causes a decrease in programmed +1 and −1 
translational frameshifting and a reduction in readthrough of UAA 
and UGA stop codons (Widerak et al., 2005). It would be interesting 
to see whether the Um1369 modification in human 16S rRNA fulfils 
a similar function, especially in the context of the discovery that pro-
grammed −1 frameshifting by the mammalian mitoribosome is nec-
essary for translation termination of two mitochondrial open reading 
frames (Temperley et al., 2010).
Our results also imply that MRM2 interacts with the intact mito-
chondrial monosome (Figure 6). Neither the bacterial RrmJ nor the 
yeast Mrm2p exhibits this property. It is possible that human MRM2 
has acquired an extra function compared with its orthologues that 
could, for example, contribute to the very final stages of joining mt-
SSU and mt-LSU into a functional mitochondrial monosome. Such 
an extra function would not be unprecedented, as dual functions of 
rRNA MTases have been reported. For instance, the bacterial MTase 
KsgA, which is responsible for dimethylation of adenines at the 
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dehydrogenase (GAPDH; (1:10,000; Abcam), rabbit anti–histone 
H4 (1:1000; Abcam), rabbit anti–SSB1 IgG (1:4000; kindly donated 
by D. Kang, Kyushu University), and mouse anti-TOM22 (1:1000, 
Abcam).
Secondary antibodies were anti-rabbit IgG-HRP (1:2000; Pro-
mega, Fitchburg, WI), anti-mouse IgG-HRP (1:2000; Promega), and 
anti-goat IgG-HRP (1:1000; Sigma-Aldrich).
siRNA gene silencing
Stealth siRNAs were obtained from Invitrogen and delivered to cells 
using Lipofectamine RNAiMAX. Stealth RNAi duplexes were gener-
ated using the following sequences:
MRM1 (siRNA1): CCAUUUGCAGCCAGAGGAAGGGUUU
MRM1 (siRNA2): GAUAAGGUCAUCACCAGCCGGAGAA
MRM1 (siRNA3): GCUAUGGAGGUGAUGGACGUGUUCU
MRM2/FTSJ2 (siRNA1): GACCCGACAUCUCAGGGACCCAUUU
MRM2/FTSJ2 (siRNA2): GGGCUGGAAGUCAAAGCCGUCGGUU
MRM2/FTSJ2 (siRNA3): GAGCAGAUGUGAUUCUGAGCGACAU
MRM3/RMTL1 (siRNA1): GACAAUAGUAAAGUCCAGGCCAUUU
MRM3/RMTL1 (siRNA2): GCAGGCUCAUUUCAGACGCUCUCAA
MRM3/RMTL1 (siRNA3): CCUUUAUGCCCAGGCUGAGAUGUCU
RNA isolation, Northern blotting, and reverse transcription 
primer extension
Total RNA from HeLa cells was isolated using TRIzol (Invitrogen) ac-
cording to the manufacturer’s instructions. For Northern blots, RNA 
was resolved on 1% (wt/vol) agarose gels containing 0.7 M formalde-
hyde in 1× 3-(N-morpholino)propanesulfonic acid buffer, transferred 
to a nylon membrane in 2× saline–sodium citrate, and hybridized with 
radioactively labeled PCR fragments corresponding to appropriate 
regions of mtDNA or nuclear 18S rDNA. For reverse transcription 
primer extension (RT-PEx), the specific 5′ 32P-labeled primer (0.1 pmol) 
was incubated with 0.5–1 μg of the total RNAs in a 10-μl solution 
containing 10 mM Tris-HCl (pH 8.0) and1 mM EDTA at 80°C for 2 min 
and cooled slowly in a PCR block. Subsequently, reverse transcription 
reactions were performed using an Omniscript RT Kit (Qiagen, 
Hilden, Germany), with the following components added to the an-
nealed RNA primer: 10× reaction buffer, dNTP mix to achieve a final 
concentration of 0.04 or 1 mM, 4 U of Omniscript reverse tran-
scriptase, and 10 U of RNasin and RNase-free water to a final volume 
of 20 μl. The reaction mixture was incubated at 37°C for 1 h, followed 
by addition of nucleic acid loading dye (2× solution of 95% forma-
mide, 18 mM EDTA, and 0.025% SDS, xylene cyanol, and bromophe-
nol blue). The reaction mixture was separated by 12.5% (vol/vol) 
PAGE containing 7 M urea. Dried gels were exposed to a storage 
phosphor screen (GE Healthcare, Little Chalfont, UK) and scanned 
using a Typhoon phosphor imaging system. The signals were quanti-
fied using ImageQuant software, and for each set of siRNA experi-
ments the ratio between A-loop–specific and 5′-end 16S rRNA runoff 
RT-PEx products (U1369/RO or U1370/RO; Figure 4) was set as 100% 
for the control transfection (cells transfected with siRNA to green 
fluorescent protein). The same ratios for the MTase siRNA–transfected 
cells were then calculated as a percentage of the controls.
The following primers were used in RT-PEx:
Homo sapiens: pAL: GATCACGTAGGACTTTAATC (Figures 1 
and 4)
p5LSU: CTGGTAGTAAGGTGGAGTG (Figure 4)
S. cerevisiae: CCCAACTCACGTAACATTTTAATTG (Figure 3)
C. elegans: CTAATATCACGTCAGATTAATTAATAG (Figure 3)
D. melanogaster: AACTCAGATCATGTAAGAATTTAAAA (Figure 3)
D. rerio: ATCACGTAGGACTATTAATC (Figure 3)
restriction sites, and the resulting fragments were cloned into 
pcDNA5-FST2 as described previously (Minczuk et al., 2011).
Maintenance and transfection of mammalian cell lines
Human HeLa cells (routinely used by us for immunofluorescence 
localization of mitochondrial proteins) were cultured in DMEM 
containing 2 mM l-glutamine (Invitrogen, Carlsbad, CA) and supple-
mented with 10% fetal calf serum (FCS; PAA Laboratories, Pasching, 
Austria). For immunofluorescence experiments, HeLa cells were 
transfected with pcDNA5-FST2 harboring MRM1, MRM2, or MRM3 
using Lipofectamine 2000 (Invitrogen) according to the manufac-
turer′ s instructions.
The Flp-In T-Rex human embryonic kidney 293T (HEK293T) cell 
line (Invitrogen), which allows for the generation of stable doxycy-
cline-inducible expression of transgenes by FLP recombinase-medi-
ated integration, was used to express the MRM1-, MRM2-, or 
MRM3-FLAG.STREP2 proteins. HEK293T cells were grown in DMEM 
containing 2 mM l-glutamine (Invitrogen) and 10% tetracycline-
free FCS (Autogen Bioclear, Calne, UK) and supplemented with 
100 μg/ml Zeocin (Invitrogen) and 15 μg/ml blasticidin (Invivogen, 
San Diego, CA). Cells were transfected using Lipofectamine 2000 
according to the manufacturer’s instructions. Twenty-four hours 
after transfection, the selective antibiotics hygromycin (100 μg/ml, 
Invivogen) and blasticidin (15 μg/ml) were added, and this selective 
medium was replaced every 3–4 d.
Cell fractionation
Cell fractionation was performed as described by Minczuk et al. 
(2011), omitting the sucrose gradient step.
FLAG-tag affinity purification
Mitochondria were isolated from HEK293T cells expressing MRM2.
FLAG, MRM3.FLAG, ICT1.FLAG, or MRPS27.FLAG essentially as 
described in Richter et al. (2010). Pelleted mitochondria were resus-
pended in lysis buffer (Sigma-Aldrich, St. Louis, MO), and IP was 
performed with a FLAG M2 affinity gel (Sigma-Aldrich) following 
manufacturer’s recommendations. Elution was conducted with FLAG 
peptide.
Immunodetection of proteins
The localization of proteins by immunofluorescence in fixed HeLa 
cells was performed as described (Minczuk et al., 2010). The following 
antibodies were used: mouse anti-Flag immunoglobulin G (IgG; 
1:200; Sigma-Aldrich) and AlexaFluor488–conjugated anti-mouse IgG 
(1:200; Life Technologies, Paisley, UK). Immunofluorescence images 
were captured using a Zeiss LSM 510 META confocal microscope.
For immunoblot analysis, equal amounts of protein correspond-
ing to total cell lysates or gradient-separated protein fractions were 
subjected to SDS–PAGE, semidry transferred to nitrocellulose mem-
branes, blocked in 5% (wt/vol) nonfat milk (Marvel) in phosphate-
buffered saline (PBS) for 1 h, and incubated with specific primary 
antibodies in 5% (wt/vol) nonfat milk in PBS for 1 h or overnight. The 
blots were further incubated with horseradish peroxidase (HRP)–
conjugated secondary antibodies in 5% nonfat milk in PBS for h and 
visualized using ECL+ (Amersham, Little Chalfont, UK).
The primary antibodies used were rabbit anti-MRM1 (1:1000; 
Sigma-Aldrich), mouse anti-FTSJ2 1:100 (MyBioSource, San Diego, 
CA), rabbit anti-RNTL1 (1:1000; Sigma-Aldrich), mouse anti-FLAG 
IgG (1:5000; Sigma-Aldrich), mouse anti-DAP3/MRPS29 (1:1000; 
Abcam, Cambridge, UK), goat anti-MRPL3 (1:1000; Abcam), mouse 
anti-MRPL12 (1:1000; Abcam), rabbit anti-MRPS18B (1:1000; Pro-
teinTech, Manchester, UK), mouse anti–glyceraldehyde-3-phosphate 
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Measurement of mitochondrial respiration
HeLa cells transfected with siRNA against MRM proteins were 
seeded at 3 × 104 cells/well in 200 μl of growth medium in XF 24-well 
cell culture microplates (Seahorse Bioscience, North Billerica, MA) 
and incubated at 37°C in 5% CO2 for 36–40 h. One hour before the 
assay, growth medium was removed and replaced with assay me-
dium (low-buffered DMEM, 10 mM l-glutamine, 1 mM sodium pyru-
vate, 2 mM glucose) with one wash of assay medium and left to 
stabilize in a 37°C non-CO2 incubator. Analysis was performed in 
quadruplicate using a XF24 Extracellular Flux Analyzer (Seahorse 
Bioscience). The wells were sequentially injected with 20 mM 2-de-
oxyglucose (2-DG) to inhibit glycolysis, 100 nM oligomycin to inhibit 
ATP-synthase, 500-1000 nM carbonylcyanide-4-trifluorometho-
xyphenylhydrazone (FCCP) to uncouple the respiratory chain, and 
200 nM rotenone to inhibit complex I. The OCR was measured for 
each well every 5 min before and after each injection. Test com-
pounds 2-DG, oligomycin, FCCP, and rotenone were all obtained 
from Sigma-Aldrich.
[35S]methionine metabolic labeling of mitochondrial 
proteins
HeLa cells transfected with siRNA against MRM proteins were grown 
as described and, then the standard medium was replaced with me-
thionine/cysteine free DMEM (Sigma-Aldrich) supplemented with 
2 mM l-glutamine, 48 μg/ml cysteine, and 50 μg/ml uridine. The 
cells were incubated for 2 × 10 min in this medium and then trans-
ferred to methionine/cysteine-free DMEM containing 10% (vol/vol) 
dialyzed FCS and emetine dihydrochloride (100 μg/ml) to inhibit 
cytosolic translation. Cells were incubated for 10 min before addi-
tion of 120 μCi/ml of [35S]methionine. Labeling was performed for 
15 min, and then the cells were washed twice with standard growth 
medium. Protein samples (30 μg) were separated on 4–12% SDS–
PAGE gels, and products were visualized and quantified using a 
PhosphorImager system with ImageQuant software (Molecular 
Dynamics, GE Healthcare).
Analysis of the mitochondrial ribosome profile on density 
gradients
Total cell lysates (0.7 mg) were loaded on a linear sucrose gradient 
(2 ml 10–30% [wt/vol]) in 50 mM Tris–HCl (pH 7.2), 10 mM Mg(OAc)2, 
80 mM NH4Cl, 0.1 M KCl, and 1 mM phenylmethylsulfonyl fluoride 
and centrifuged for 2 h, 15 min at 100,000 × gmax at 4°C (39,000 rpm; 
Beckman Coulter TLS-55 rotor). Twenty fractions (of 100 μl each) were 
collected, and 10-μl aliquots were analyzed by Western blotting.
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